Featured image

Vesna Ćorić CV

1. Personal information

 

Vesna Ćorić, M.D. PhDc

Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 2 Pasterova Street, Belgrade, Serbia

Telephone: +381-63-3643-271

Fax: +381-11-3643-270

E mail: drcoricvesna@gmail.com

Date of Birth: 20 March 1985.

Gender: Female

2. Education

 

2013 – present : Residency in Laboratory medicine, Faculty of Medicine, University of Belgrade, Serbia

May 2011 : State examination, Certificate issued by the Ministry of Health Republic of Serbia

2010/2011 – present: PhD studies in Molecular medicine, Faculty of Medicine, University of Belgrade, Serbia

2004 – 2010: Graduate studies,Faculty of Medicine, University of Belgrade, Serbia

2000 – 2004 : High School Diploma with Honors, Sixth Belgrade High School, Belgrade, Serbia

3. Work Experience

 

2011 – present : Research assistant, employed on the project entitled ‘The role of glutathione S-transferase in susceptibility to disease (Project number 175052, supported by the Ministry of education and science, Serbia), working at Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 2 Pasterova Street, Belgrade, Serbia

2010 – present: Graduate teaching assistant, Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 2 Pasterova Street, Belgrade, Serbia

2007 – 2010 : Student teaching assistant, Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 2 Pasterova Street, Belgrade, Serbia

2007 – 2008: Student teaching assistant, Institute of Medical Pathology, Faculty of Medicine, University of Belgrade, 1 Dr Subotica Street, Belgrade, Serbia

2006 – 2008 : Editor-in-Chief, “Medicinar” student magazine, Faculty of Medicine, University of Belgrade, 8 Dr Subotica Street, Belgrade, Serbia

2005 – 2006: Student teaching assistant, Institute of Human Genetics, Faculty of Medicine, University of Belgrade, 2 Pasterova Street,Belgrade, Serbia

 

4. Research Experience

 

2009 – present: Project entitled ‘The role of glutathione S-transferase in susceptibility to disease

(Project number 175052, supported by the Ministry of education and science, Serbia)

Representative references

 

1. Stamenkovic M, Radic T, Stefanovic I, Coric V, Sencanic I, Pljesa-Ercegovac M, Matic M, Jaksic V, Simic T, Savic-Radojevic A. GSTO2 polymorphism Asn142Asp modifies the risk of age-related cataract in smokers and subjects exposed to UV irradiation. Clin Experiment Ophthalmol. 2013; doi: 10.1111/ceo.12180.

2. Djukic TI, Savic-Radojevic AR, Pekmezovic TD, Matic MG, Pljesa-Ercegovac MS, Coric VM, Radic TM, Suvakov SR, Krivic BN, Dragicevic DP, Simic TP. Glutathione s-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients. PLoS One, 2013; 8(9):e74724.

3. Ercegovac М, Jović N, Simić T, Beslać-Bumbaširević Lj, Sokić D, Savić-Radojević A, Matić M, Jovanović D, Ristić A, Đukić T, Šuvakov S, Ćorić V, Mimić-Oka J, Plješa-Ercegovac M. Аntiepileptic drugs affect protein, lipid and DNA oxidative damage and antioxidant defense in patients with epilepsy. JMB, 2013; 32(2):121–130.

4. Suvakov S, Damjanovic T, Stefanovic A, Pekmezovic T, Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Djukic T, Coric V, Jakovljevic J, Ivanisevic J, Pljesa S, Jelic-Ivanovic Z, Mimic-Oka J, Dimkovic N, Simic T. Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. Nephrol Dial Transplant, 2013; 28(1):202-12.

5. Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V and Simic T. GSTA1, GSTM1, GSTP1 and GSTT1 polymorphism and susceptibility to smoking-related bladder cancer: a case-control study. Urol Oncol, 2013; 31(7):1184-92

6. Coric V, Pljesa-Ercegovac M, Matic M, Krivic B, Suvakov S, Tulic C, Mimic-Oka J, Simic T. The role of GSTM1 and GSTT1 polymorphism in patients with renal cell carcinoma. JMB, 2010; 29(3):204-210.

5. Academic mobility

 

ERAWEB (ERASMUS–WESTERN BALKANS)

2013 : 3 month period on a short term scientific mission at the Department of Oncology, Faculty of Medicine, University of Torino (Italy), project entitled “Metabolic characterization of chemosensitive and chemoresistant tumors, to discover new biomarkers and design a more personalized therapy”

2012 : SFRR-E/IUBMB Summer School 2012 “Dietary factors and redox signalling”, Spetses, Greece

7-day Summer School

6. Academic distinctions

 

Best poster Presentation, “Glutathione S‐transferase single nucleotide gene polymorphisms and susceptibility to renal cell carcinoma: Serbian case‐control study”, SFRR-E/IUBMB Summer School 2012, Spetses, Greece, 2012

Best Presentation in Session, “Genetic polymorphism of GSTM1 and GSTT1 in patients with renal cell carcinoma” (oral presentation), 51st Serbian Medical Students’ Congress, Ohrid, Macedonia, 2010

Best Presentation in Session, “Genetic polymorphism of GSTM1 in patients with renal cell carcinoma“, (oral

presentation), International Medical Students’ Congress, Novi Sad, Serbia, 2009

First Prize, “The cytotoxicity of plant xanthones in glioma cell line” (poster presentation), 17th Annual International Ain

Shams Medical Students’ Congress, Cairo, Egypt, 2009

7. Memberships

 

2011 – present : Society for Free Radicals Research (SFRR)

2011 – present : Serbian society for mitochondrial and free radical physiology

 

8. Languages

 

Serbian – mother tongue

English – Cambridge ESOL: Certificate of Proficiency in English, CPE

Italian – Inlingua Certificate: B1 level